Literature DB >> 8424945

Probing the combining site of an anti-carbohydrate antibody by saturation-mutagenesis: role of the heavy-chain CDR3 residues.

D A Brummell1, V P Sharma, N N Anand, D Bilous, G Dubuc, J Michniewicz, C R MacKenzie, J Sadowska, B W Sigurskjold, B Sinnott.   

Abstract

The carbohydrate-binding site in Fab fragments of an antibody specific for Salmonella serogroup B O-polysaccharide has been probed by site-directed mutagenesis using an Escherichia coli expression system. Of the six hypervariable loops, the CDR3 of the heavy chain was selected for exhaustive study because of its significant contribution to binding-site topography. A total of 90 mutants were produced and screened by an affinity electrophoresis/Western blotting method. Those of particular interest were further characterized by enzyme immunoassay, and on this basis seven of the mutant Fabs were selected for thermodynamic characterization by titration microcalorimetry. With regard to residues that hydrogen bond to ligand through backbone interactions, Gly102H could not be substituted, while several side chains could be introduced at Gly100H and Tyr103H with relatively little effect on antigen binding. There was, however, a preference for nonpolar side chains at position 103H. Substitution of His101H with carboxylate and amide side chains gave mutants with binding affinities approaching that of the wild type; complete side-chain removal by mutation to Gly was tolerated with a 10-fold reduction in binding constant. Analysis of binding by titration microcalorimetry revealed some dramatic thermodynamic changes hidden by the similarity of the binding constants. Similar effects were observed with residue changes in an Arg-Asp salt-bridge at the base of the loop. These results indicate that alterations to higher affinity anti-carbohydrate antibodies are characterized by an enthalpy-entropy compensation factor which allows for fundamental changes in the nature of the binding interactions but impedes engineering for increases in affinity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8424945     DOI: 10.1021/bi00055a024

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  The structure of apo protein-tyrosine phosphatase 1B C215S mutant: more than just an S --> O change.

Authors:  G Scapin; S Patel; V Patel; B Kennedy; E Asante-Appiah
Journal:  Protein Sci       Date:  2001-08       Impact factor: 6.725

2.  Thermodynamics and density of binding of a panel of antibodies to high-molecular-weight capsular polysaccharides.

Authors:  Shannon L Harris; Philip Fernsten
Journal:  Clin Vaccine Immunol       Date:  2008-11-12

3.  Contribution of asparagine residues to the stabilization of a proteinaceous antigen-antibody complex, HyHEL-10-hen egg white lysozyme.

Authors:  Akiko Yokota; Kouhei Tsumoto; Mitsunori Shiroishi; Takeshi Nakanishi; Hidemasa Kondo; Izumi Kumagai
Journal:  J Biol Chem       Date:  2009-12-28       Impact factor: 5.157

4.  Isothermal titration calorimetry reveals differential binding thermodynamics of variable region-identical antibodies differing in constant region for a univalent ligand.

Authors:  Tarun K Dam; Marcela Torres; C Fred Brewer; Arturo Casadevall
Journal:  J Biol Chem       Date:  2008-09-19       Impact factor: 5.157

5.  In vitro scanning saturation mutagenesis of an antibody binding pocket.

Authors:  E A Burks; G Chen; G Georgiou; B L Iverson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

6.  Mutational landscape of antibody variable domains reveals a switch modulating the interdomain conformational dynamics and antigen binding.

Authors:  Patrick Koenig; Chingwei V Lee; Benjamin T Walters; Vasantharajan Janakiraman; Jeremy Stinson; Thomas W Patapoff; Germaine Fuh
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-05       Impact factor: 11.205

Review 7.  Carbohydrate vaccines: developing sweet solutions to sticky situations?

Authors:  Rena D Astronomo; Dennis R Burton
Journal:  Nat Rev Drug Discov       Date:  2010-04       Impact factor: 84.694

8.  Applying Pose Clustering and MD Simulations To Eliminate False Positives in Molecular Docking.

Authors:  Spandana Makeneni; David F Thieker; Robert J Woods
Journal:  J Chem Inf Model       Date:  2018-03-09       Impact factor: 4.956

9.  Peptide epitopes recognized by a human anti-cryptococcal glucuronoxylomannan antibody.

Authors:  H Zhang; Z Zhong; L A Pirofski
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

10.  Basis for selection of improved carbohydrate-binding single-chain antibodies from synthetic gene libraries.

Authors:  S J Deng; C R MacKenzie; T Hirama; R Brousseau; T L Lowary; N M Young; D R Bundle; S A Narang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.